Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Clear all

311 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200115
200210
200311
200412
200519
200613
200714
200812
200915
201011
201110
201214
201313
20149
20159
201615
201714
20187
201910
20207
20218
20226
20235
20248
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed172
Terminated58
Recruiting25
Unknown status22
Active, not recruiting18
Withdrawn12
Not yet recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center41
Fred Hutchinson Cancer Center21
Novartis Pharmaceuticals15
Masonic Cancer Center, University of Minnesota13
National Heart, Lung, and Blood Institute (NHLBI)13
National Cancer Institute (NCI)10
Bristol-Myers Squibb7
Gruppo Italiano Malattie EMatologiche dell'Adulto7
St. Jude Children's Research Hospital7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive311
Leukemia, Myeloid, Acute124
Precursor Cell Lymphoblastic Leukemia-Lymphoma115
Myelodysplastic Syndromes108
Leukemia84
Leukemia, Lymphocytic, Chronic, B-Cell65
Lymphoma, Non-Hodgkin65
Hodgkin Disease63
Leukemia, Myeloid, Chronic-Phase58
Multiple Myeloma44

Trials

Showing 1 to 25 of 311. Each trial links to its page on Pharma Observatory.

211 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.